Hui‐Lin Wu

1.4k total citations
34 papers, 1.1k citations indexed

About

Hui‐Lin Wu is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hui‐Lin Wu has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Hepatology and 9 papers in Molecular Biology. Recurrent topics in Hui‐Lin Wu's work include Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (12 papers) and Liver Disease Diagnosis and Treatment (6 papers). Hui‐Lin Wu is often cited by papers focused on Hepatitis B Virus Studies (18 papers), Hepatitis C virus research (12 papers) and Liver Disease Diagnosis and Treatment (6 papers). Hui‐Lin Wu collaborates with scholars based in Taiwan, United States and China. Hui‐Lin Wu's co-authors include Pei‐Jer Chen, Ding‐Shinn Chen, Li–Rung Huang, Chwan‐Chuen King, Day‐Yu Chao, Gwong‐Jen J. Chang, Chun‐Jen Liu, Chuan‐Liang Kao, Jiiang‐Huei Jeng and Mei‐Chi Chang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Hui‐Lin Wu

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui‐Lin Wu Taiwan 18 626 439 307 218 191 34 1.1k
Margarita Pardo Spain 23 1.0k 1.7× 1.1k 2.5× 104 0.3× 229 1.1× 158 0.8× 49 1.7k
Yongfen Xu China 18 411 0.7× 263 0.6× 320 1.0× 267 1.2× 310 1.6× 29 1.0k
Luwen Zhang United States 19 347 0.6× 113 0.3× 225 0.7× 300 1.4× 360 1.9× 49 1.2k
Isabel Gallego Spain 16 234 0.4× 211 0.5× 235 0.8× 191 0.9× 48 0.3× 35 762
J. A. Grimaud France 17 204 0.3× 113 0.3× 151 0.5× 126 0.6× 50 0.3× 38 752
Kurt H. Edelmann United States 11 504 0.8× 115 0.3× 220 0.7× 380 1.7× 1.0k 5.3× 16 1.7k
Nicholas J. Megjugorac United States 14 366 0.6× 98 0.2× 211 0.7× 222 1.0× 1.1k 5.6× 15 1.5k
Ayako Kurioka United Kingdom 16 447 0.7× 105 0.2× 140 0.5× 106 0.5× 1.5k 7.7× 20 1.7k
Theoni Petropoulou Germany 13 244 0.4× 61 0.1× 326 1.1× 292 1.3× 607 3.2× 20 1.1k
Zohreh Sharifi Iran 15 410 0.7× 218 0.5× 159 0.5× 132 0.6× 144 0.8× 130 844

Countries citing papers authored by Hui‐Lin Wu

Since Specialization
Citations

This map shows the geographic impact of Hui‐Lin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Lin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Lin Wu more than expected).

Fields of papers citing papers by Hui‐Lin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Lin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Lin Wu. The network helps show where Hui‐Lin Wu may publish in the future.

Co-authorship network of co-authors of Hui‐Lin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Lin Wu. A scholar is included among the top collaborators of Hui‐Lin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Lin Wu. Hui‐Lin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Cheng‐Pu, Mi‐Hua Tao, Hui‐Lin Wu, et al.. (2024). Major HBV splice variant encoding a novel protein important for infection. Journal of Hepatology. 80(6). 858–867. 7 indexed citations
2.
Chang, Sui‐Yuan, Yu‐Nong Gong, Chung‐Guei Huang, et al.. (2023). The emergence and successful elimination of SARS-CoV-2 dominant strains with increasing epidemic potential in Taiwan’s 2021 outbreak. Heliyon. 9(12). e22436–e22436. 2 indexed citations
3.
Li, Qi, et al.. (2023). [Dihydromyricetin improves Parkinson's disease-like lesions in T2DM rats by activating AMPK/ULK1 pathway].. PubMed. 75(1). 59–68. 2 indexed citations
4.
Wu, Hui‐Lin, et al.. (2023). Isolation of murine hepatic myeloid cells with high yield and purity using immunomagnetic beads for subset analysis. STAR Protocols. 4(4). 102592–102592. 2 indexed citations
5.
Iwamoto, Masashi, Junna Kawasaki, Shohei Kojima, et al.. (2021). Identification of novel avian and mammalian deltaviruses provides new insights into deltavirus evolution. Virus Evolution. 7(1). veab003–veab003. 22 indexed citations
6.
Wu, Shang‐Hsin, Mei‐Hwei Chang, Yahui Chen, et al.. (2021). The ESCRT-III molecules regulate the apical targeting of bile salt export pump. Journal of Biomedical Science. 28(1). 19–19. 3 indexed citations
7.
Wu, Li‐Ling, Wei‐Hao Peng, Hui‐Lin Wu, et al.. (2019). Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice. Hepatology. 69(6). 2364–2380. 36 indexed citations
8.
Wu, Hui‐Lin, Jia‐Horng Kao, Chen‐Hua Liu, et al.. (2014). Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications. Journal of Gastroenterology and Hepatology. 29(8). 1629–1636. 26 indexed citations
9.
Kao, Jia‐Horng, Hui‐Lin Wu, Tai‐Chung Tseng, et al.. (2014). Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection. Hepatology International. 9(1). 35–42. 13 indexed citations
10.
Kao, Jia‐Horng, Hui‐Lin Wu, Tai‐Chung Tseng, et al.. (2013). Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post‐treatment or spontaneously. Liver International. 34(6). e71–9. 11 indexed citations
11.
Lin, Yi‐Jiun, Hui‐Lin Wu, Ding‐Shinn Chen, & Pei‐Jer Chen. (2012). Hepatitis B Virus Nucleocapsid but Not Free Core Antigen Controls Viral Clearance in Mice. Journal of Virology. 86(17). 9266–9273. 18 indexed citations
12.
Wu, Hui‐Lin, Stephanie Fang–Tzu Kuo, Jia‐Horng Kao, et al.. (2011). Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B. Hepatology International. 6(3). 591–597. 17 indexed citations
13.
Chao, Day‐Yu, Chwan‐Chuen King, Wei‐Kung Wang, et al.. (2005). Strategically examining the full-genome of dengue virus type 3 in clinical isolates reveals its mutation spectra. Virology Journal. 2(1). 72–72. 44 indexed citations
14.
Wu, Hui‐Lin, Li–Rung Huang, Chun‐Jen Liu, et al.. (2005). RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant. Gastroenterology. 128(3). 708–716. 92 indexed citations
15.
16.
Liu, Chun‐Jen, Pei‐Jer Chen, Ming–Yang Lai, et al.. (2003). A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology. 124(1). 80–90. 58 indexed citations
17.
Chen, Hui‐Ling, et al.. (1998). Long-term culture of hepatocytes from human adults. Journal of Biomedical Science. 5(6). 435–440. 36 indexed citations
18.
Chen, Pei‐Jer, et al.. (1997). Molecular biology of hepatitis D virus: Research and potential for application. Journal of Gastroenterology and Hepatology. 12(9-10). S188–92. 11 indexed citations
19.
Wu, Hui‐Lin, et al.. (1997). Inhibition of hepatitis delta virus genomic ribozyme self-cleavage by aminoglycosides. Journal of Biomedical Science. 4(5). 208–216. 35 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margarita Pardo Breakdown of academic impact, for papers by Yongfen Xu Breakdown of academic impact, for papers by Luwen Zhang Breakdown of academic impact, for papers by Isabel Gallego Breakdown of academic impact, for papers by J. A. Grimaud Breakdown of academic impact, for papers by Kurt H. Edelmann Breakdown of academic impact, for papers by Nicholas J. Megjugorac Breakdown of academic impact, for papers by Ayako Kurioka Breakdown of academic impact, for papers by Theoni Petropoulou Breakdown of academic impact, for papers by Zohreh Sharifi
Rankless by CCL
2026